Ibrahim Rami Mossad, Steenstrup Jensen Signe, Juel Jacob
Department Plastic and Reconstructive Surgery, Herlev Hospital, Copenhagen, Denmark.
Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark.
J Orthop. 2018 Sep 6;15(4):963-966. doi: 10.1016/j.jor.2018.08.039. eCollection 2018 Dec.
Clear cell sarcoma (CCS) previously known as malignant melanoma (MM) of the soft tissue, although, similar in morphology to MM, contemporary histopathologic and cytogenetic techniques have made this diagnosis obsolete, as it is now possible to distinguish between CCS and MM. CCS is often diagnosed in young adults with median age of 25 years. Overall mortality is generally poor, and the 5-year survival is between 40 and 60%. Hence, early diagnosis and radical surgery are key in the treatment of this extremely rare malignancy of the soft tissue comprising only about 1% of all sarcomas. This article present an overview of this rare malignancy.
透明细胞肉瘤(CCS)以前被称为软组织恶性黑色素瘤(MM),尽管其形态与MM相似,但现代组织病理学和细胞遗传学技术已使这种诊断过时,因为现在可以区分CCS和MM。CCS常发生于年轻成年人,中位年龄为25岁。总体死亡率通常较高,5年生存率在40%至60%之间。因此,早期诊断和根治性手术是治疗这种极为罕见的软组织恶性肿瘤的关键,该肿瘤仅占所有肉瘤的约1%。本文概述了这种罕见的恶性肿瘤。